Skip to content

A Randomized Control Trial Comparing Reverse Bone Grafting combined with Core Decompression and Core Decompression alone in patients diagnosed with Avascular Necrosis of Femoral Head

A Randomized Control Trial Comparing Reverse Bone Grafting and Core Decompression in Avascular Necrosis of Femoral Head. - NIL

Status
Recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/02/079967
Enrollment
40
Registered
2025-02-06
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: M873- Other secondary osteonecrosis Health Condition 2: O- Medical and Surgical

Interventions

Intervention1: Reverse bone grafting and core decompression in avascular necrosis of femoral head: Reverse bone grafting offers structural support and osteoinductive properties, facilitating bone rege

Sponsors

Jawaharlal Nehru Medical College
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients giving informed consent 2) Ficat and Arlet staging grade one, two and three

Exclusion criteria

Exclusion criteria: 1) Patients not willing to participate in the study 2) Ficat and Arlet staging grade four 3) Ipsilateral co morbidities or deformities affecting knee, spine or ankle 4) Any other condition affecting True Outcome analysis based on criterias included

Design outcomes

Primary

MeasureTime frame
1) Functional outcome analysis and radiological outcome analysis in Core Decompression with Reverse bone grafting 2) Functional outcome analysis and radiological outcome analysis in Core Decompression without Reverse Bone grafting 3) Comparing the outcomes of Core Decompression with Reverse Bone Grafting and without Reverse bone grafting groupsTimepoint: pre operative, 6 weeks, 12 weeks and 6 months

Secondary

MeasureTime frame
Functional outcome analysis and radiological outcome analysis in Core Decompression with Reverse Bone grafting enriched with biologics ( Platelet Rich plasma and Bone Marrow Aspiration Concentrate )Timepoint: pre operative, 6 weeks, 12 weeks and 6 months

Countries

India

Contacts

Public ContactDr Sandeep Shrivastava

Datta Meghe Institute of Medical Science and research

ceohospitals@gmail.com9765404068

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026